Onexio Biosystems
BioTech/Drugs - N/A, N/A, US
Onexio Biosystems Employees
Onexio Biosystems Senior Management
Onexio Biosystems Details
Onexio Biosystems LLC develops technologies for high-throughput (96, 384 and 1536-well) co-culture and multi-culture applications. Traditional HTS screens typically utilize a single reporter cell type that lacks important confounding biology including drug metabolism, paracrine and endocrine cell:cell interactions. Screening results are therefore plagued by false-negatives and false-positives that stem from the oversimplified biology of mono-culture assays. Co-culture of a reporter cell assay with other cell types is viable solution to this problem, but traditional compartmentalized co-culture assays are not well suited for robotic HTS. A better solution would be to retrofit existing reporter assays in a technically simple manner that seamlessly integrates with existing robotic infrastructure (e.g. no new equipment required) and is also compatible with 384 and 1536 well HTS. Our first product, the microDUO fills this market need.
Onexio Biosystems Technologies
Email Providers
Gmail
Tag Management
Google Tag Manager
Fonts
Google Font API
Hosting
Blue Host
Other
Google Apps
CSS and JavaScript Libraries
Bootstrap Framework